Market Cap

Luye Pharma Group Ltd Market Capitalization:

HK$13.39 Billion

HKD as of Jan. 1, 2024

US$1.71 Billion

business Luye Pharma Group Ltd Company Profile

Luye Pharma Group Ltd Main Stock Listing

HKEX: 2186

Market Capitalization History of Luye Pharma Group Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $586.39 B
Johnson & Johnson $387.50 B
Merck $296.51 B
AbbVie $285.06 B
Roche $240.44 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Luye Pharma Group Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 HK$13.39 B 0.34%
Jan. 1, 2023 HK$13.35 B 10.03%
Jan. 1, 2022 HK$12.13 B -12.85%
Jan. 1, 2021 HK$13.92 B -22.82%
Jan. 1, 2020 HK$18.03 B -13.55%
Jan. 1, 2019 HK$20.86 B -16.60%
Jan. 1, 2018 HK$25.01 B 35.99%
Jan. 1, 2017 HK$18.39 B -19.69%
Jan. 1, 2016 HK$22.90 B -30.96%
Jan. 1, 2015 HK$33.17 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Luye Pharma Group Ltd Categories

China languages Healthcare languages Drug Manufacturers—General
China Healthcare China Drug Manufacturers—General

Stocks & Indices

Luye Pharma Group Ltd has the following listings and related stock indices.


Stock: HKEX: 2186

Stock: FSX: LUP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.